JP2010518386A5 - - Google Patents

Download PDF

Info

Publication number
JP2010518386A5
JP2010518386A5 JP2009548631A JP2009548631A JP2010518386A5 JP 2010518386 A5 JP2010518386 A5 JP 2010518386A5 JP 2009548631 A JP2009548631 A JP 2009548631A JP 2009548631 A JP2009548631 A JP 2009548631A JP 2010518386 A5 JP2010518386 A5 JP 2010518386A5
Authority
JP
Japan
Prior art keywords
hemoglobin
level
sample
free
pregnant female
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009548631A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010518386A (ja
JP5604111B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/001051 external-priority patent/WO2008098734A1/en
Publication of JP2010518386A publication Critical patent/JP2010518386A/ja
Publication of JP2010518386A5 publication Critical patent/JP2010518386A5/ja
Application granted granted Critical
Publication of JP5604111B2 publication Critical patent/JP5604111B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009548631A 2007-02-12 2008-02-12 子癇前症の診断及び治療 Expired - Fee Related JP5604111B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0700339 2007-02-12
SE0700339-5 2007-02-12
PCT/EP2008/001051 WO2008098734A1 (en) 2007-02-12 2008-02-12 Diagnosis and treatment of preeclampsia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013150603A Division JP5792772B2 (ja) 2007-02-12 2013-07-19 子癇前症の診断及び治療

Publications (3)

Publication Number Publication Date
JP2010518386A JP2010518386A (ja) 2010-05-27
JP2010518386A5 true JP2010518386A5 (enExample) 2011-03-31
JP5604111B2 JP5604111B2 (ja) 2014-10-08

Family

ID=39295873

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009548631A Expired - Fee Related JP5604111B2 (ja) 2007-02-12 2008-02-12 子癇前症の診断及び治療
JP2013150603A Expired - Fee Related JP5792772B2 (ja) 2007-02-12 2013-07-19 子癇前症の診断及び治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013150603A Expired - Fee Related JP5792772B2 (ja) 2007-02-12 2013-07-19 子癇前症の診断及び治療

Country Status (18)

Country Link
US (3) US8568999B2 (enExample)
EP (3) EP2111555B1 (enExample)
JP (2) JP5604111B2 (enExample)
KR (2) KR101608501B1 (enExample)
AU (1) AU2008214837B2 (enExample)
BR (1) BRPI0808340A2 (enExample)
CA (1) CA2674204C (enExample)
DK (2) DK2111555T3 (enExample)
EA (2) EA022609B1 (enExample)
ES (2) ES2426069T3 (enExample)
HR (2) HRP20130809T1 (enExample)
HU (1) HUE031613T2 (enExample)
MX (2) MX347788B (enExample)
NZ (1) NZ578077A (enExample)
PL (2) PL2614832T3 (enExample)
PT (2) PT2111555E (enExample)
WO (1) WO2008098734A1 (enExample)
ZA (1) ZA200905101B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX347788B (es) * 2007-02-12 2017-05-12 A1M Pharma Ab Diagnosis y tratamiento de preeclampsia.
HUE027953T2 (en) * 2008-07-18 2017-01-30 A1M Pharma Ab Medical use of the radical scavenger and antioxidant alpha-1 microglobulin
WO2011095981A1 (en) * 2010-02-03 2011-08-11 St. John's Research Institute An in-vitro method for characterizing hemoglobin variant
DK2550535T3 (en) * 2010-03-24 2015-07-27 Preelumina Diagnostics Ab HBF AND A1M MARKING AT AN EARLY STAGE
US9903865B2 (en) * 2010-03-31 2018-02-27 Sekisui Medical Co., Ltd. Assay, immunochromatographic test strip, and assay reagent kit for measuring an analyte, using a hematocrit correction
CA2886489A1 (en) 2011-10-14 2013-04-18 Aarhus Universitet Diagnostic and prognostic use of prombp-complexes
MX357656B (es) * 2012-09-05 2018-07-18 A1M Pharma Ab Alfa-1-microglobulina para usarse en tratamiento de enfermedades relacionadas a mitocondrias.
US20140186332A1 (en) * 2012-12-28 2014-07-03 NX Pharmagen Biomarkers of preterm birth
US10928402B2 (en) 2012-12-28 2021-02-23 Nx Prenatal Inc. Treatment of spontaneous preterm birth
EA201791978A1 (ru) 2015-03-16 2018-01-31 А1М Фарма Аб Биомаркеры преэклампсии
KR101732933B1 (ko) 2015-07-29 2017-05-08 영남대학교 산학협력단 신생아의 성장 또는 심혈관계 질환 예후 진단 방법
EP3384076A4 (en) 2015-12-04 2019-09-25 Nx Prenatal Inc. USE OF CIRCULATING MICROPARTICLES TO STRATIFY THE RISK ON A SPONTANEOUS SPRING BIRTH
US12253490B2 (en) 2018-03-19 2025-03-18 Regeneron Pharmaceuticals, Inc. Microchip capillary electrophoresis assays and reagents
US12259355B2 (en) 2018-03-19 2025-03-25 Regeneron Pharmaceuticals, Inc. Microchip capillary electrophoresis assays and reagents
BR112020015291B1 (pt) * 2018-03-19 2023-09-26 Regeneron Pharmaceuticals, Inc Tampão de amostra de eletroforese aquoso, método para identificar contaminantes ou impurezas em uma amostra de fármaco proteico, e, kit
US11418353B2 (en) * 2019-08-26 2022-08-16 Micron Technology, Inc. Security descriptor generation
CN111626280B (zh) * 2020-04-13 2021-09-07 北京邮电大学 一种无定位点答题卡识别方法和装置
JP7543575B2 (ja) * 2022-09-05 2024-09-02 栄研化学株式会社 遊離ヘモグロビン測定試薬、遊離ヘモグロビン測定方法および抗ヘモグロビン抗体
KR20250145250A (ko) * 2024-03-28 2025-10-13 계명대학교 산학협력단 Ccl20 및 csf3 단백질 또는 상기 단백질을 코딩하는 유전자를 유효성분으로 포함하는 태아성장제한 진단용 바이오마커 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1337778A1 (ru) 1984-06-25 1987-09-15 Новосибирский государственный медицинский институт Способ диагностики т жести позднего токсикоза беременных
US5079171A (en) 1988-09-15 1992-01-07 Adeza Biomedical Corporation Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin
US5238819A (en) 1988-12-14 1993-08-24 The Regents Of The University Of California Diagnostic assay for the detection of preeclampsia
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5108898A (en) 1989-01-18 1992-04-28 Peters John H Use of fibronectin having a variable included type III repeat sequence as a marker for toxemia in pregnancy
US5612034A (en) * 1990-10-03 1997-03-18 Redcell, Inc. Super-globuling for in vivo extended lifetimes
US5166133A (en) 1991-04-17 1992-11-24 Cetus Corporation Method for inhibing adhesion of white blood cells to endothelial cells
US6103691A (en) 1994-03-23 2000-08-15 Tschesche; Harald Utilisation of angiogenin and/or α1 -microglobulin and/or complement factor D in order to inhibit the secretion of proteins
US5849474A (en) * 1995-12-06 1998-12-15 Olson; Camilla M. Diagnosis of preeclampsia in mammals
US5910482A (en) * 1996-03-19 1999-06-08 Board Of Regents, The University Of Texas System Treatment or prevention of preeclampsia, eclampsia with calcitonin gene related peptide, CGRP analog, progestational agent, nitric oxide source, and cyclooxygenase inhibitor
US6169816B1 (en) * 1997-05-14 2001-01-02 Applied Imaging, Inc. Identification of objects of interest using multiple illumination schemes and finding overlap of features in corresponding multiple images
JP2001348342A (ja) 2001-04-12 2001-12-18 Nippon Zoki Pharmaceut Co Ltd 免疫調整・抗炎症剤
DE60233301D1 (de) 2001-05-04 2009-09-24 Biosite Inc Diagnostische marker für akute herzerkrankungen und verfahren des gebrauchs
ES2284911T3 (es) 2001-09-04 2007-11-16 Iq Corporation B.V. Determinacion y cuantificacion de poblaciones de globulos rojos en muestras.
CN1522369A (zh) * 2002-03-29 2004-08-18 ���µ�����ҵ��ʽ���� 血液处理方法及其装置、血红蛋白类测定方法及其装置
DE10237423A1 (de) 2002-08-16 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von LCK-Inhibitoren für die Behandlung von immunologischen Erkrankungen
WO2005002515A2 (en) * 2003-06-20 2005-01-13 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
AR045074A1 (es) 2003-07-23 2005-10-12 Applied Research Systems Uso de cd164 soluble en desordenes inflamatorios y autoinmunes
CA2547124A1 (en) * 2003-11-26 2005-06-09 Sanofi-Aventis Deutschland Gmbh Tubular proteinuria as an indicator for elevated cardiovascular risk
WO2005093413A2 (en) * 2004-03-22 2005-10-06 Yale University Diagnosis and treatment of preeclampsia
US20070292421A1 (en) * 2005-07-28 2007-12-20 Feinberg Bruce B Method for treating preeclampsia
GB0600916D0 (en) 2006-01-17 2006-02-22 Perkinelmer Instr Las Inc detecting and predicting pre-eclampsia
CA2636353A1 (en) 2006-01-18 2007-07-26 Wick, Immunologische Diagnostik U. Beratung Kg Test systems for the analysis of polypeptides and cells adhering to silicones
MX347788B (es) 2007-02-12 2017-05-12 A1M Pharma Ab Diagnosis y tratamiento de preeclampsia.
WO2009108073A1 (en) 2008-02-28 2009-09-03 Auckland Uniservices Limited Biomarkers for prediction of preeclampsia and/or cardiovascular disease
HUE027953T2 (en) 2008-07-18 2017-01-30 A1M Pharma Ab Medical use of the radical scavenger and antioxidant alpha-1 microglobulin
DK2550535T3 (en) 2010-03-24 2015-07-27 Preelumina Diagnostics Ab HBF AND A1M MARKING AT AN EARLY STAGE

Similar Documents

Publication Publication Date Title
JP2010518386A5 (enExample)
JP2020521117A5 (enExample)
JP5792772B2 (ja) 子癇前症の診断及び治療
JP2012509477A5 (enExample)
NZ603492A (en) Humanized anti-factor d antibodies and uses thereof
NZ600828A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP2006502416A5 (enExample)
JP6639392B2 (ja) 胎盤成長因子2の選択的測定法
ZA200805787B (en) Detection of cancer by elevated levels of BCL-2
JP2012507030A5 (enExample)
CN105785051B (zh) 血清中可溶性Tim‑3蛋白作为诊断慢性肾病的标志物
JP5801895B2 (ja) 全身性炎症反応症候群を伴わない術後感染症の検出方法
CN108738347B (zh) 辅助肝细胞癌患者的再发风险预测的方法、装置、计算机程序制品及试剂盒
Haslene-Hox et al. Quantification of the concentration gradient of biomarkers between ovarian carcinoma interstitial fluid and blood
JP2018520366A5 (enExample)
AU2020418522A1 (en) Preeclampsia biomarkers and use thereof
CN112805565A (zh) 对肝型脂肪酸结合蛋白质进行定量的方法、其定量用试剂盒、肾疾病的检查方法、其检查试剂盒及伴随诊断药
KR102336498B1 (ko) 간세포암 진단용 면역글로불린 a 마커 및 이의 용도
US8697368B2 (en) Diagnostic marker for lung cancer comprising HPαR as active ingredient
Nishino Hypocretin measurements in the CSF, and blood and brain tissue: basic and clinical applications
WO2007008092A3 (en) Diagnostic kit for the examination of animal sera for the presence of anti-rhd antibodies and a diagnostic kit for detecting the rhd virus
KR100834932B1 (ko) 알파1산 당단백질과 아사이알로 알파1산 당단백질의 비율을 이용한 간질환 진단킷트
JP2016535266A5 (enExample)
JP2016515534A (ja) 子癇症及び子癇前症を治療するための方法
JP2013519083A5 (enExample)